Skip to main content

CORRECTION article

Front. Vet. Sci., 02 August 2023
Sec. Veterinary Surgery
Volume 10 - 2023 | https://doi.org/10.3389/fvets.2023.1252778

Corrigendum: Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: a prospective, block-randomized, double-blinded, placebo-controlled clinical trial

This article is a correction to:

  1. Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: A prospective, block-randomized, double-blinded, placebo-controlled clinical trial

    1. Read original article
\r\nNaruepon KampaNaruepon Kampa1Duangdaun KaenkangplooDuangdaun Kaenkangploo1Supranee JitpeanSupranee Jitpean1Thanikul SrithunyaratThanikul Srithunyarat1Suvaluk SeesupaSuvaluk Seesupa1Somphong HoisangSomphong Hoisang2Karn YongvanitKarn Yongvanit2Phanthit KamlangchaiPhanthit Kamlangchai2Pongsatorn TuchpramukPongsatorn Tuchpramuk3B. Duncan X. Lascelles,, B. Duncan X. Lascelles4,5,6*
  • 1Division of Surgery, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, Thailand
  • 2Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, Thailand
  • 3Faculty of Veterinary Sciences, Mahasarakham University, Maha Sarakham, Thailand
  • 4Translational Research in Pain Program, Comparative Pain Research and Education Centre, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States
  • 5Center for Translational Pain Research, Department of Anesthesiology, Duke University, Durham, NC, United States
  • 6Thurston Arthritis Center, UNC, Chapel Hill, NC, United States

A corrigendum on
Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: a prospective, block-randomized, double-blinded, placebo-controlled clinical trial

by Kampa, N., Kaenkangploo, D., Jitpean, S., Srithunyarat, T., Seesupa, S., Hoisang, S., Yongvanit, K., Kamlangchai, P., Tuchpramuk, P., and Lascelles, B. D. X. (2023). Front. Vet. Sci. 10:1033188. doi: 10.3389/fvets.2023.1033188

In the published article, there was an error in the Funding statement. The funding statement stated that the funder was VetzPetz Asia Company when it was actually Pharmalink International Ltd. The correct Funding statement appears below.

Funding

This work was funded by Pharmalink International Ltd., Central, Hong Kong and supported by the Faculty of Veterinary Medicine, Khon Kaen University. The authors declare that the funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: OA, marine-based fatty acid, non-steroidal anti-inflammatory drug (NSAID), gait analysis, PVF

Citation: Kampa N, Kaenkangploo D, Jitpean S, Srithunyarat T, Seesupa S, Hoisang S, Yongvanit K, Kamlangchai P, Tuchpramuk P and Lascelles BDX (2023) Corrigendum: Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: a prospective, block-randomized, double-blinded, placebo-controlled clinical trial. Front. Vet. Sci. 10:1252778. doi: 10.3389/fvets.2023.1252778

Received: 04 July 2023; Accepted: 25 July 2023;
Published: 02 August 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Kampa, Kaenkangploo, Jitpean, Srithunyarat, Seesupa, Hoisang, Yongvanit, Kamlangchai, Tuchpramuk and Lascelles. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: B. Duncan X. Lascelles, ZHhsYXNjZWwmI3gwMDA0MDtuY3N1LmVkdQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.